Help Your Patients Get Back in Range
KYZATREX®:
Twice-daily Oral Testosterone Replacement Therapy
KYZATREX is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
A good choice for your patients. A good decision for your practice.
Cash Only / No Prior Authorizations / No Insurance Hassles
The TRT Your Patients Want
“When I first discovered I had Low T, I went with pellet therapy. While pellets seemed fine at first, they eventually became too much of a hassle – the painful implant process, scar tissue buildup and activity restrictions just weren’t for me, especially when the effects started wearing off before the next dose. As soon as I heard there was an oral option, that’s when I switched to KYZATREX. I love the convenience of the capsules, and my testosterone levels are in the normal range! It’s made a real difference in how I feel.”
David W.
Real Patient Taking KYZATREX
Twice-daily, No Needles or Gels
The Convenience of KYZATREX Capsules
Embrace the ease of twice-daily KYZATREX capsules, a convenient form of testosterone treatment.
With KYZATREX, you can offer a therapy that:
- Eliminates administration pain
- Avoids the mess associated with gels
- Eradicates transference risks
KYZATREX’s capsule form is designed to deliver a straightforward approach to testosterone therapy. As a cash-pay medication, KYZATREX provides a convenient option and removes the complications of insurance.
KYZATREX® Clinical Data
The efficacy of KYZATREX was evaluated in a 6-month open-label clinical study involving 139 hypogonadal men (median age of 50 years; range 22 to 66 years). The primary efficacy endpoint was the percentage of KYZATREX-treated patients with mean plasma total testosterone concentration (Cavg) over 24-hours within the normal range of 222-800 ng/dl on the final PK visit of the study at Day 90. KYZATREX demonstrated the following at Day 90:
Stay Informed
Receive
Communication
from KYZATREX
References:
- KYZATREX [prescribing information]. Raleigh, NC: Marius Pharmaceuticals; 2023.
- Data on file. Raleigh, NC: Marius Pharmaceuticals, 2020.